Drug Type Small molecule drug |
Synonyms- |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 2/3 |
First Approval Date- |
Regulation- |
Molecular FormulaC4H6O5 |
InChIKeyBJEPYKJPYRNKOW-UHFFFAOYSA-N |
CAS Registry6915-15-7 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Xerostomia | Phase 3 | Spain | 01 Jan 2011 | |
| Water-Electrolyte Imbalance | Preclinical | China | 17 Nov 2021 |
Phase 2/3 | 185 | (Malic Acid 1%) | obytaanrkx(rudmufaegt) = cgkytwajrf jssqizthzz (lzdcrcbavt, 0.6) View more | - | 05 Apr 2016 | ||
Placebo (Control) | obytaanrkx(rudmufaegt) = fmvcqprhiy jssqizthzz (lzdcrcbavt, 0.5) View more |





